That's EXACTLY CORRECT!!!
Cytodyn doesn't come anywhere close to BioClonetics-ENZC.
The ONLY reason that penny stock company went from the penny range to $10 within 52 weeks on the OTC, is due mainly to them having a Big Pharma partner. That's the fundamental reason why. It has to be because they're still in the midst of clinical trials and have brought NOTHING to market, but yet, not long ago they were trading at $10 PPS. Now they're trading in the $2 range and nothing has really changed for them.
Yes, they're making progress BUT what they have is FAR less of an application for treating HIV than our company. If fact, there's no comparison!
They still have not overcome "HIV viral escape" with their Monoclone Ab, and it still requires the 3X per week dual application with HIV Standard of Care Antiretroviral Therapy (ART) medications that comes with substantial morbidity, side effects, and clinical complications.
Then to boot, their Monoclone Ab has NOT been shown to be effective on most HIV strains.
BioClonetics-ENZC holds the GOLD for not only HIV treatment but its near total eradication of it altogether in up to 95% of all HIV strains with a stand alone Monotherapy that has no side effects! Nothing out there can touch this, NOTHING!.
I say these things with the conviction of me being a clinical trials research physician with NIH scientific background who has been involved in dozens of Big Pharma patient trials.
Now that we are nearing the official Merger with BioClonetics AND we have Dr. Moss on board, these two key developments puts us on an all new level, and IMO Dr. Moss will prove to be the catalyst that fast tracks this company to Warp Speed federal classification of getting our products to market, not only for HIV treatment, but also Covid-19, and a host of other viral infectious diseases.
Now if everyone can just be patient, you're going to be rewarded in the near future when all the pieces fully come into place which is definitely in progress in a major way!!!
I perceive that within a year from now, this company will be trading in the $5-$7 range, and when a Big Pharma partner has been identified and is on board post success with the Primate Studies at U.C. Davis, from that position onward I see this company trading in the $10+ range if not much higher, then shortly after transitioning to NASDAQ with major institutional buying of shares, BUT it's going to take PATIENCE!!! After that, Sky's the Limit maybe even +$300 with or without buy out!
My personal position in all of this is ADD and HOLD in that order, and not to become worried if the PPS drops or trades sideways. I could care less for reason it's simply more opportunity to snap up shares at a ridiculously low PPS. At the current trading range of this company, my target goal ownership is 20M to 50M shares! I'm already well on the way to achieving that!
DON'T WORRY....BE HAPPY!!!
